CervoMed (CRVO) Interest Expenses (2010 - 2026)
CervoMed (CRVO) posted Interest Expenses of $328.0 for Q1 2026, down 23.0% sequentially from $426.0 in Q3 2025, and down 58.43% YoY from $789.0 in Q1 2025.
CervoMed (CRVO) Interest Expenses (2010 - 2026) Analysis & Trends
CervoMed has reported Interest Expenses for 17 years, with the latest figure at $328.0 in Q1 2026.
- Quarterly Interest Expenses fell 58.43% year-over-year to $328.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $328.0 (down 58.43% YoY) and the FY2024 annual result came in at $2784.0, down 99.22% from the prior year.
- Interest Expenses eased to $328.0 in Q1 2026 per CRVO's latest filing, from $426.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $358340.0 in Q4 2023 and troughed at -$15413.0 in Q4 2022.
- A 5-year average of $45577.5 and a median of $4221.0 in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2023: Interest Expenses slumped 100.07% in 2022, then surged 2424.92% in 2023.
- Over 5 years, Interest Expenses stood at -$15413.0 in 2022, then soared by 2424.92% to $358340.0 in 2023, then plunged by 99.22% to $2784.0 in 2024, then plunged by 84.7% to $426.0 in 2025, then slipped by 23.0% to $328.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $328.0, $426.0, and $5109.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.00 |
| Jun 30, 2026 | 27.00 |
| Mar 31, 2026 | 328.00 |
| Mar 31, 2026 | 328.00 |
| Sep 30, 2025 | 426.00 |
| Sep 30, 2025 | 426.00 |
| Jun 30, 2025 | 5,109.00 |
| Jun 30, 2025 | 5,109.00 |
| Mar 31, 2025 | 789.00 |
| Mar 31, 2025 | 789.00 |
| Dec 31, 2024 | 2,784.00 |
| Dec 31, 2024 | 2,784.00 |
| Sep 30, 2024 | 522.00 |
| Sep 30, 2024 | 522.00 |
| Jun 30, 2024 | 23,008.00 |
| Jun 30, 2024 | 23,008.00 |
| Dec 31, 2023 | 358,340.00 |
| Dec 31, 2023 | 358,340.00 |
| Jun 30, 2023 | 35,638.00 |
| Jun 30, 2023 | 35,638.00 |